Gouyer, Valérie <br/><br/>
Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.  [electronic resource] 

 -  Cancer  Apr 2005 
 - 1676-84 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.20965  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Adult<br/>Aged<br/>Biomarkers, Tumor--metabolism<br/>Blotting, Northern<br/>Carcinoma, Large Cell--metabolism<br/>Carcinoma, Non-Small-Cell Lung--metabolism<br/>Carcinoma, Squamous Cell--metabolism<br/>Case-Control Studies<br/>Disease Progression<br/>Humans<br/>Lung--metabolism<br/>Lung Neoplasms--metabolism<br/>Lymphatic Metastasis<br/>Matrix Metalloproteinase 1--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>RNA, Messenger--genetics<br/>Survival Rate<br/>Tissue Inhibitor of Metalloproteinase-1--genetics<br/>Tissue Inhibitor of Metalloproteinase-2--genetics